CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
August 2019—Binding Site’s Immunologicals Group added two native tick-borne encephalitis viral antigens to its line of products for in vitro diagnostic manufacturing and research applications. The standard version of the antigen as well as the premium version are for use as components in enzyme immunoassay testing procedures.
The company also released two separate grades of C-reactive protein—a 99 percent purity grade and an 80 percent pure grade—designed for use as components in solid phase enzyme immunoassay test procedures as well as in the manufacturing of calibration and quality control materials. Both are screened and found to be negative for HIV, HbsAg, and HCV.
Pages: 1 2